CANY
ZYME icon

Caxton Associates (New York)’s Zymeworks ZYME Stock Holding History

Caxton Associates (New York)’s Portfolio ZYME Stock Details ZYME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-45,810
Closed -$575K – 700
2024
Q3 		$575K Buy
+45,810
New +$499K 0.02% 344
2023
Q2 		– Sell
-120,772
Closed -$1.09M – 674
2023
Q1 		$1.09M Buy
120,772
+1,633
+1% +$14.2K 0.16% 128
2022
Q4 		$936K Buy
+119,139
New +$837K 0.06% 122

Other funds holding ZYME

EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Caxton Associates (New York)'s ZYME Position: Q4 2024 in Review

Caxton Associates (New York) sold out of Zymeworks (ZYME) in Q4 2024, closing a stake of 45,810 shares — an estimated $575K sold.

Caxton Associates (New York) first reported a position in ZYME in Q4 2022 and held it in 3 quarters. The position peaked at $1.09M in Q1 2023. 172 funds tracked by Wall St. Rank hold ZYME as of Q4 2024.

  • Caxton Associates (New York) reported no remaining Zymeworks position as of Q4 2024 after selling out during the quarter.
  • Caxton Associates (New York) sold 45,810 Zymeworks shares in Q4 2024, an estimated $575K.
  • Caxton Associates (New York) first reported a position in Zymeworks in Q4 2022 and held it in 3 quarters.
  • Caxton Associates (New York)'s Zymeworks position peaked at $1.09M in Q1 2023.
  • 172 funds tracked by Wall St. Rank held Zymeworks as of Q4 2024.

Based on Caxton Associates (New York)'s 13F filing for Q4 2024, filed 14 Feb 2025.